Will domestic entry of Avastin make Roche worried?
Domestic clinical trials of biosimilars have been actively conducted towards ‘Avastin(generic name: bevacizumab),’ a VEGF(Vascular endothelial growth factor) targeted anticancer drug.
On the 5th, Quintiles Transnational Korea acquired approval for the clinical trial of ‘BI 695502 concentrate for...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
